H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition

BACKGROUND: Adriamycin (ADM) is a drug commonly used for treating gastric cancer (GC). However, chemoresistance presents an obstacle to achieving successful outcomes in patients treated with chemotherapy. This study aimed to explore the effect of long non-coding RNA (lncRNA) H19 on chemoresistance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaodong, Ding, Wenbin, Shen, Weiguang, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798114/
https://www.ncbi.nlm.nih.gov/pubmed/35117758
http://dx.doi.org/10.21037/tcr-20-1736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798114/
https://www.ncbi.nlm.nih.gov/pubmed/35117758
http://dx.doi.org/10.21037/tcr-20-1736

Ejemplares similares